Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Publication year range
1.
Diabetes Res Clin Pract ; 96(2): e47-9, 2012 May.
Article in English | MEDLINE | ID: mdl-22425436

ABSTRACT

We investigated two single nucleotide polymorphisms of the NOS3 gene in type 2 diabetic patients (n=93) and healthy non-diabetic controls (n=76) and their relationship with smoking habits, body mass index, hypertension and dyslipidemia. Results showed that eNOS polymorphism rs891512 (G24943A) is associated with hypertension in Chilean individuals (p<0.05).


Subject(s)
Diabetes Mellitus, Type 2/genetics , Hypertension/enzymology , Nitric Oxide Synthase Type III/metabolism , Polymorphism, Single Nucleotide/genetics , Body Mass Index , Chile , Diabetes Mellitus, Type 2/enzymology , Humans , Hypertension/genetics , Nitric Oxide Synthase Type III/genetics , Smoking
2.
Rev Med Chil ; 126(7): 833-7, 1998 Jul.
Article in Spanish | MEDLINE | ID: mdl-9830777

ABSTRACT

The new Classification and Diagnostic Criteria for Diabetes Mellitus (DM), prepared by a group of experts from the American Diabetes Association is presented and analyzed. On an etiopathogenic basis, it designates Insulin Dependent and Non Insulin Dependent as Type 1 and Type 2 respectively. It specifies DM having specific known causes. It maintains Gestational Diabetes and Glucose Intolerance and adds the Impaired Fasting Glucose Condition. It recommends fasting plasma glucose for search and diagnosis, and lowers the level to > or = 126 mg/dl instead of > or = 140 mg/dl, due to its association with chronical complications of DM. It maintains the diagnostic criteria of random and post charge glycemia > or 200 mg/dl. It does not alter the glucose intolerance figure (140-200 mg/dl in OGTT) and introduces fasting abnormality > or = 110 and < 126 mg/dl. It encourages the search with fasting glucose every 3 years in individuals aged over 45, and at more frequent intervals in younger individuals with high risk factors. Analysis of the report allows to conclude that, although the classification does not introduce any significant change in daily clinical use, its pathogenic orientation makes future innovations possible. The preferential use of fasting glucose > or = 126 mg/dl for diagnosis of DM has theoretical basis and practical advantages. Identification of individuals with impaired fasting glucose allows to detect, in a simple manner, a high risk group in which to start preventive measures. However, there is a percentage of cases which are not diagnosed by fasting glycemia, but are diagnosed by OGTT, therefore the latter should not be discarded.


Subject(s)
Diabetes Mellitus/classification , Diabetes Mellitus/diagnosis , Blood Glucose/analysis , Glucose Intolerance , Humans
SELECTION OF CITATIONS
SEARCH DETAIL